Full history for every metric is available with a Kvantra account
Human Xtensions Ltd. (HUMX.TA)
Key financial summary
Financials in ILS| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | ILS m | 21 | 3 | 3 | 5 | 1 | 0 | 0 |
| Operating profit | ILS m | -1 | -3 | |||||
| Net profit | ILS m | -29 | -54 | -45 | -37 | -23 | -1 | -4 |
| EPS reported | ILS | -0.50 | -1.38 | |||||
| Operating cashflow per share | ILS | -2.32 | -1.25 | |||||
| Capex per share | ILS | 0.00 | 0.00 | |||||
| FCF per share | ILS | -2.32 | -1.25 | |||||
| Free cash flow | ILS m | -6 | -3 | |||||
| Net debt | ILS m | -1 | 0 | |||||
| Book value equity | ILS m | 1 | - | |||||
| Book value per share | ILS | 0.56 | - | |||||
| Number of shares | m | 2.68 | 2.52 | |||||
| DPS (TTM paid) | ILS | 0.00 | 0.00 |
Financial summary
Financials in ILS| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.48 | -3.19 | |||||
| P/S LTM | x | 0.00 | 0.00 | |||||
| P/FCF LTM | x | -0.12 | -2.50 | |||||
| EV/EBITDA LTM | x | 0.42 | -5.70 | |||||
| EV/Sales LTM | x | 0.00 | 0.00 | |||||
| Earnings Yield LTM | % | -178.57% | -478.61% | |||||
| FCF Yield | % | -828.42% | -39.96% | |||||
| Quality | ||||||||
| ROE | % | -85.37% | -566.43% | |||||
| ROIC | % | -80.54% | -931.27% | |||||
| Operating margin | % | 0.00% | 0.00% | |||||
| Gross margin | % | 0.00% | 0.00% | |||||
| FCF/Sales | % | - | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -100.00% | -100.00% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | -5.22 | |||||
| Net Debt/EBITDA | x | 1.51 | -0.26 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -139.12% | 4.80% | |||||
| Net debt/Equity | x | -0.67 | - | |||||
| Gross debt/equity | x | 0.00 | - | |||||
Company overview
Human Xtensions Ltd. is dedicated to conceiving, fabricating, promoting, and selling adaptable medical equipment intended for less invasive surgical interventions. Their product line features HandX, a sophisticated handheld electromechanical instrument specifically designed for laparoscopic procedures, in addition to surgical accessories like the Fenestrated Grasper, Monopolar Hook, and Needle Holder. This firm was established in 2012 and operates from its base in Netanya, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Human Xtensions Ltd. (HUMX.TA)
Human Xtensions Ltd. is dedicated to conceiving, fabricating, promoting, and selling adaptable medical equipment intended for less invasive surgical interventions. Their product line features HandX, a sophisticated handheld electromechanical instrument specifically designed for laparoscopic procedures, in addition to surgical accessories like the Fenestrated Grasper, Monopolar Hook, and Needle Holder. This firm was established in 2012 and operates from its base in Netanya, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free